منابع مشابه
Organelle targeting: third level of drug targeting
Drug discovery and drug delivery are two main aspects for treatment of a variety of disorders. However, the real bottleneck associated with systemic drug administration is the lack of target-specific affinity toward a pathological site, resulting in systemic toxicity and innumerable other side effects as well as higher dosage requirement for efficacy. An attractive strategy to increase the ther...
متن کاملThird international nanomedicine and drug delivery symposium
The University of Maryland–Baltimore’s (UMB’s) Center for Nanomedicine and Cellular Delivery (CNCD) (www.pharmacy.umaryland.edu/nanomedicine), located in the School of Pharmacy, hosted the Third International Nanomedicine and Drug Delivery Symposium on September 26–27, 2005. Organized collectively by Hamid Ghandehari (UMB), Alexander Kabanov (University of Nebraska Medical Center, Omaha, Nabras...
متن کاملNeuromonics Tinnitus Treatment: third clinical trial.
OBJECTIVES The Neuromonics Tinnitus Treatment combines the use of a novel approach to acoustic stimulation with a structured program of counseling and support by a clinician specifically trained in tinnitus rehabilitation. The distinctive acoustic component has been designed to provide stimulation to auditory pathways deprived by hearing loss, engage positively with the limbic system, and allow...
متن کاملMethods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
BACKGROUND New injection drug users (IDUs) are at high risk for blood-borne viral infections. Given U.S. policy to only fund proven-effective HIV prevention interventions, insights into conducting intervention trials among young IDUs are provided here by describing methods and participants' characteristics in the CIDUS III/DUIT study. METHODS In 2002-2004, 15-30-year-old IDUs in Baltimore, Ch...
متن کاملregulatory aspects of clinical trials in iran: third year report of clinical trial committee in food and drug organization.
clinical trial committee (ctc) has been established in food and drug organization (fdo), in 2003 to assure efficacy and safety of all types of medicinal products which are meant to be registered in iran drug list and/or obtain market authorization.all clinical trial files, meeting minutes and databases in ctc secretariat in fdo were reviewed. relevant information and data extracted, analyzed an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1984
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.288.6422.1008-b